FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2603979662> ?p ?o ?g. }

• W2603979662 endingPage "733" @default.
• W2603979662 startingPage "726" @default.
• W2603979662 abstract "Background and purpose Significant effects on clinical/neuroradiological disease activity have been reported in patients with relapsing–remitting multiple sclerosis treated with delayed-release dimethyl fumarate (DMF) in phase III DEFINE/CONFIRM trials. We conducted a post hoc analysis of integrated data from DEFINE/CONFIRM to evaluate the effect of DMF on achieving no evidence of disease activity (NEDA) in patients with relapsing–remitting multiple sclerosis. Methods The analysis included patients randomized to DMF 240 mg twice daily, placebo or glatiramer acetate (CONFIRM only) for ≤2 years. A time-to-event method was used to estimate the percentage of patients achieving NEDA. Clinical NEDA (no relapses/no 12-week confirmed disability progression) was analysed in the intention-to-treat (ITT) population. Neuroradiological (no new/newly enlarging T2 hyperintense lesions/no gadolinium-enhancing lesions) and overall NEDA (clinical and neuroradiological NEDA) were analysed in the magnetic resonance imaging (MRI) cohort. Results The ITT and MRI populations comprised 1540 and 692 patients, respectively. The percentage of patients with clinical NEDA (ITT population) and neuroradiological NEDA (MRI cohort) was higher with DMF versus placebo over 2 years [clinical NEDA: 38.9% relative reduction; hazard ratio (HR), 0.61; 95% confidence interval (CI), 0.52-0.72; P < 0.0001; neuroradiological NEDA: 40.0% relative reduction; HR, 0.60; 95% CI, 0.49–0.73; P < 0.0001]. The percentage of patients achieving overall NEDA (MRI cohort) was also higher with DMF (26%) versus placebo (12%) over 2 years, with a relative risk reduction of 42.7% (HR, 0.57; 95% CI, 0.48–0.69; P < 0.0001). Conclusions A significantly higher percentage of patients treated with DMF achieved NEDA status over 2 years compared with placebo." @default.
• W2603979662 created "2017-04-07" @default.
• W2603979662 creator A5015754502 @default.
• W2603979662 creator A5029734617 @default.
• W2603979662 creator A5032922361 @default.
• W2603979662 creator A5037249165 @default.
• W2603979662 creator A5054874316 @default.
• W2603979662 creator A5062220148 @default.
• W2603979662 creator A5062685257 @default.
• W2603979662 creator A5078067575 @default.
• W2603979662 date "2017-03-22" @default.
• W2603979662 modified "2023-10-16" @default.
• W2603979662 title "Effect of delayed-release dimethyl fumarate on no evidence of disease activity in relapsing-remitting multiple sclerosis: integrated analysis of the phase III DEFINE and CONFIRM studies" @default.
• W2603979662 cites W1966849321 @default.
• W2603979662 cites W1967838438 @default.
• W2603979662 cites W1976243978 @default.
• W2603979662 cites W1994670953 @default.
• W2603979662 cites W1999493557 @default.
• W2603979662 cites W2086372696 @default.
• W2603979662 cites W2093009907 @default.
• W2603979662 cites W2105053272 @default.
• W2603979662 cites W2112165124 @default.
• W2603979662 cites W2123021165 @default.
• W2603979662 cites W2143771994 @default.
• W2603979662 cites W2173315418 @default.
• W2603979662 cites W2173983813 @default.
• W2603979662 cites W2290657810 @default.
• W2603979662 cites W2916040650 @default.
• W2603979662 doi "https://doi.org/10.1111/ene.13272" @default.
• W2603979662 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5413827" @default.
• W2603979662 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28328179" @default.
• W2603979662 hasPublicationYear "2017" @default.
• W2603979662 type Work @default.
• W2603979662 sameAs 2603979662 @default.
• W2603979662 citedByCount "48" @default.
• W2603979662 countsByYear W26039796622017 @default.
• W2603979662 countsByYear W26039796622018 @default.
• W2603979662 countsByYear W26039796622019 @default.
• W2603979662 countsByYear W26039796622020 @default.
• W2603979662 countsByYear W26039796622021 @default.
• W2603979662 countsByYear W26039796622022 @default.
• W2603979662 countsByYear W26039796622023 @default.
• W2603979662 crossrefType "journal-article" @default.
• W2603979662 hasAuthorship W2603979662A5015754502 @default.
• W2603979662 hasAuthorship W2603979662A5029734617 @default.
• W2603979662 hasAuthorship W2603979662A5032922361 @default.
• W2603979662 hasAuthorship W2603979662A5037249165 @default.
• W2603979662 hasAuthorship W2603979662A5054874316 @default.
• W2603979662 hasAuthorship W2603979662A5062220148 @default.
• W2603979662 hasAuthorship W2603979662A5062685257 @default.
• W2603979662 hasAuthorship W2603979662A5078067575 @default.
• W2603979662 hasBestOaLocation W26039796621 @default.
• W2603979662 hasConcept C118552586 @default.
• W2603979662 hasConcept C126322002 @default.
• W2603979662 hasConcept C126838900 @default.
• W2603979662 hasConcept C142724271 @default.
• W2603979662 hasConcept C143409427 @default.
• W2603979662 hasConcept C204787440 @default.
• W2603979662 hasConcept C207103383 @default.
• W2603979662 hasConcept C27081682 @default.
• W2603979662 hasConcept C2776819417 @default.
• W2603979662 hasConcept C2778577042 @default.
• W2603979662 hasConcept C2779134260 @default.
• W2603979662 hasConcept C2780640218 @default.
• W2603979662 hasConcept C2908647359 @default.
• W2603979662 hasConcept C44249647 @default.
• W2603979662 hasConcept C67761136 @default.
• W2603979662 hasConcept C71924100 @default.
• W2603979662 hasConcept C72563966 @default.
• W2603979662 hasConcept C90924648 @default.
• W2603979662 hasConcept C99454951 @default.
• W2603979662 hasConceptScore W2603979662C118552586 @default.
• W2603979662 hasConceptScore W2603979662C126322002 @default.
• W2603979662 hasConceptScore W2603979662C126838900 @default.
• W2603979662 hasConceptScore W2603979662C142724271 @default.
• W2603979662 hasConceptScore W2603979662C143409427 @default.
• W2603979662 hasConceptScore W2603979662C204787440 @default.
• W2603979662 hasConceptScore W2603979662C207103383 @default.
• W2603979662 hasConceptScore W2603979662C27081682 @default.
• W2603979662 hasConceptScore W2603979662C2776819417 @default.
• W2603979662 hasConceptScore W2603979662C2778577042 @default.
• W2603979662 hasConceptScore W2603979662C2779134260 @default.
• W2603979662 hasConceptScore W2603979662C2780640218 @default.
• W2603979662 hasConceptScore W2603979662C2908647359 @default.
• W2603979662 hasConceptScore W2603979662C44249647 @default.
• W2603979662 hasConceptScore W2603979662C67761136 @default.
• W2603979662 hasConceptScore W2603979662C71924100 @default.
• W2603979662 hasConceptScore W2603979662C72563966 @default.
• W2603979662 hasConceptScore W2603979662C90924648 @default.
• W2603979662 hasConceptScore W2603979662C99454951 @default.
• W2603979662 hasIssue "5" @default.
• W2603979662 hasLocation W26039796621 @default.
• W2603979662 hasLocation W26039796622 @default.
• W2603979662 hasLocation W26039796623 @default.
• W2603979662 hasLocation W26039796624 @default.
• W2603979662 hasOpenAccess W2603979662 @default.
• W2603979662 hasPrimaryLocation W26039796621 @default.
• W2603979662 hasRelatedWork W2085438061 @default.

• next